Back to search
FDAFDA · Food and drugs·Recall number D-0423-2018

0.2% Ropivacaine HCI (Preservative Free) in 0.9 Sodium Chloride, Epidural, 250 mL Yellow Cassette, Rx only, PharMEDium Serivces, LLC

Published February 21, 2018 · Recall initiated: February 5, 2018

Summary

FDA records drug Class II recall D-0423-2018, published February 21, 2018 and initiated February 5, 2018. Recalling firm: PharMEDium Services, LLC; Status: Terminated; Reported quantity: 21 Cassettes; Lot: Lot #: 180030029D, Exp 2/18/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of assurance of sterility: Three lots were released where there was a failure to follow proper testing and investigation procedures. Product may be out of specification (OOS) for endotoxin.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
PharMEDium Services, LLC
Distributor
Product was distributed to SC, FL, NY, NY,WA
Lot
Lot #: 180030029D, Exp 2/18/18
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 0.2% Ropivacaine HCI (Preservative Free) in 0.9 Sodium Chloride, Epidural, 250 mL Yellow Cassette, Rx only, PharMEDium Serivces, LLC recalled?

Yes. FDA published recall D-0423-2018 on February 21, 2018. Reported hazard: Lack of assurance of sterility: Three lots were released where there was a failure to follow proper testing and investigation procedures. Product may be out of specification (OOS) for endotoxin.

What should I do if I have this product?

Voluntary: Firm initiated · Letter